- Home
- ACT vs ELAN Comparison
ACT vs ELAN Comparison
Compare ACT & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACT
- ELAN
- Stock Information
- Founded
- ACT 1981
- ELAN 1954
- Country
- ACT United States
- ELAN United States
- Employees
- ACT N/A
- ELAN N/A
- Industry
- ACT Specialty Insurers
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- ACT Finance
- ELAN Health Care
- Exchange
- ACT Nasdaq
- ELAN Nasdaq
- Market Cap
- ACT 5.2B
- ELAN 5.4B
- IPO Year
- ACT 2021
- ELAN 2018
- Fundamental
- Price
- ACT $34.40
- ELAN $10.42
- Analyst Decision
- ACT Buy
- ELAN Buy
- Analyst Count
- ACT 4
- ELAN 6
- Target Price
- ACT $36.50
- ELAN $15.00
- AVG Volume (30 Days)
- ACT 210.3K
- ELAN 3.9M
- Earning Date
- ACT 04-30-2025
- ELAN 05-07-2025
- Dividend Yield
- ACT 2.15%
- ELAN N/A
- EPS Growth
- ACT 6.33
- ELAN N/A
- EPS
- ACT 4.37
- ELAN 0.68
- Revenue
- ACT $1,201,774,000.00
- ELAN $4,439,000,000.00
- Revenue This Year
- ACT $3.35
- ELAN $3.20
- Revenue Next Year
- ACT $3.78
- ELAN $4.26
- P/E Ratio
- ACT $7.87
- ELAN $15.31
- Revenue Growth
- ACT 4.17
- ELAN 0.50
- 52 Week Low
- ACT $28.98
- ELAN $10.03
- 52 Week High
- ACT $37.42
- ELAN $18.80
- Technical
- Relative Strength Index (RSI)
- ACT 56.24
- ELAN 42.62
- Support Level
- ACT $33.46
- ELAN $10.45
- Resistance Level
- ACT $35.17
- ELAN $10.85
- Average True Range (ATR)
- ACT 0.62
- ELAN 0.36
- MACD
- ACT 0.12
- ELAN 0.03
- Stochastic Oscillator
- ACT 71.05
- ELAN 40.10
About ACT Enact Holdings Inc.
Enact Holdings Inc is a private mortgage insurance company serving the United States housing finance market. The principal mortgage insurance customers are originators of residential mortgage loans who determine which mortgage insurer or insurers will be used for the placement of mortgage insurance written on loans originated. The company is engaged in writing and assuming residential mortgage guaranty insurance.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.